INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/Companies & Institutions/Cochin Cancer Research Centre
Back to Newsroom
🏢Organization Dossier

Cochin Cancer Research Centre

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

11 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
National Governance & Policy 01 Nov 2026, 02:00 PM IST

Cochin Cancer Research Centre to Be Built Into Centre of Excellence, Says Chief Minister V.D. Satheesan

The Cochin Cancer Research Centre will be developed into a centre of excellence under a five-year plan to be rolled out in phases, Chief Minister V.D. Satheesan said on Tuesday. The announcement signals a structured push to strengthen cancer care infrastructure, research capacity and specialised treatment delivery in Kerala.

By RDU Global Wire5 min read
Macro Economy & Fiscal Policy19 Nov 2026, 08:00 AM IST

Cochin Airport Launches India’s First Transfer Cargo Security Hold Area

Cochin International Airport has operationalised India’s first Transfer Cargo Security Hold Area, a move that could materially streamline cargo movement through one of the country’s key aviation gateways. The facility is designed to reduce transfer cargo screening to a random 5 per cent, cutting transit time and lowering handling costs for shippers and logistics operators.

5 min readRead →
Macro Economy & Fiscal Policy09 Oct 2026, 06:59 PM IST

Cochin Shipyard Begins Steel Cutting for 70-Tonne Tug Order from Svitzer Denmark

Cochin Shipyard has marked the start of construction on a new series of 70-tonne bollard pull tugs for Svitzer A/S of Denmark, a contract that underscores India’s growing role in specialised maritime manufacturing. The TRAnsverse-class vessels are designed for demanding close-quarter operations and are expected to serve a wide range of ship types in difficult weather and tidal conditions.

5 min readRead →
Macro Economy & Fiscal Policy09 Oct 2026, 03:29 PM IST

Cochin Shipyard Begins Steel Cutting for 70-Tonne Bollard Pull Tugs for Svitzer A/S

Cochin Shipyard has commenced steel cutting for a new series of 70-tonne bollard pull tugs being built for Svitzer A/S of Denmark, marking a fresh export-linked order for India’s shipbuilding sector. The TRAnsverse-class vessels are designed for demanding close-quarter operations and are intended to serve a wide range of ship sizes and operating conditions, including difficult weather and tidal environments.

6 min readRead →
National Governance & Policy18 Nov 2026, 08:00 PM IST

GCC Issues 124 De-Occupation Notices for Coastal Buildings Over CRZ Violations

The Greater Cochin Corporation has issued 124 de-occupation notices to buildings along the coast, citing unauthorised construction, deviations from approved plans and violations of Coastal Regulation Zone norms. The action signals a stricter enforcement push in one of Kerala’s most environmentally sensitive urban belts, where development pressure has long outpaced regulatory compliance.

5 min readRead →
National Governance & Policy09 Oct 2026, 02:12 AM IST

Cusat shifts classes online as chickenpox cases surge, postpones exams

Cochin University of Science and Technology has moved all classes on its Thrikkakara and Marine campuses online until October 16 after a sharp rise in chickenpox infections among students. The university has also asked infected students to leave hostels and postponed scheduled examinations as it moves to contain further spread.

4 min readRead →
Global Health & Biotech17 Nov 2026, 08:00 AM IST

Biotech Leads Bullish Market Talk as CG Oncology’s Bladder Cancer Data Fuels Breakout

Biotechnology has emerged as the most bullishly discussed corner of the market, with investor sentiment strengthening after a series of clinical readouts and regulatory milestones. The latest catalyst is CG Oncology’s bladder cancer program, which delivered a Phase 3 win that is now reshaping expectations for the company and adding momentum to the broader biotech trade.

6 min readRead →
Global Markets & Equities05 Nov 2026, 08:00 PM IST

Boehringer Returns to Sino Biopharma in $7.4 Billion Cancer Pact

Boehringer Ingelheim has struck a new oncology partnership with Sino Biopharma, reviving a relationship that now carries a headline value of up to $7.4 billion. The deal centers on preclinical bispecific T-cell engagers and antibody-drug conjugates, underscoring how large drugmakers are still willing to pay for early-stage cancer assets with long-dated optionality. The agreement adds another major cross-border licensing transaction to a market already defined by capital discipline, pipeline replenishment and intense competition for differentiated oncology platforms. For investors, the structure signals both the scale of demand for next-generation cancer modalities and the long development runway that will determine how much of the deal value ultimately becomes payable.

6 min readRead →
National Governance & Policy02 Nov 2026, 08:00 PM IST

Nadda Inaugurates Advanced Radiotherapy Facility at AIIMS Rajkot, Reaffirms Push for Better Cancer Care

Union Health Minister J.P. Nadda inaugurated an advanced radiotherapy facility at AIIMS Rajkot, underscoring the government’s commitment to expanding access to modern cancer treatment. The move is part of a broader effort to strengthen tertiary care infrastructure and reduce the burden on patients who often travel long distances for specialised oncology services.

5 min readRead →
Global Health & Biotech26 Oct 2026, 08:00 PM IST

Landmark Melanoma Vaccine Trial Cuts Recurrence or Death Risk by 42%, Raising Stakes for Cancer Biotech

A first-of-its-kind personalized cancer vaccine has reduced the risk of melanoma recurrence or death by 42% in a landmark trial, according to reports from the European Society for Medical Oncology meeting. The result strengthens the case for individualized immunotherapy and could reshape investor expectations for Moderna, Merck, and the broader oncology biotech sector.

4 min readRead →
World Politics & Diplomacy26 Oct 2026, 02:00 PM IST

Vanessa Trump Says She Is Cancer-Free Six Months After Breast Cancer Diagnosis

Vanessa Trump, the former wife of Donald Trump Jr., says she is cancer-free six months after publicly revealing that she had been diagnosed with breast cancer. Her announcement adds a personal health update to a family long watched through the lens of American politics and public scrutiny. The disclosure, made months after her initial diagnosis in May, underscores the private toll of a disease that affects millions while drawing renewed attention to the intersection of celebrity, family life, and public resilience.

5 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Cochin Cancer Research Centre: